IDBIOLOGICS INC
Monoclonal antibody combination for seasonal influenza prevention
- Sector
- Biotech
- Headquarters
- Nashville, TN
- Founded
- 2017
- Latest Form D
- $3.1M, May 2020
- Total capital
- $5.9M
- Federal grants
- $889K
- 3 awards · 2019
- Rank in peer group#99 of 392
- Private capital raised
- $3.1M
- 1 Form D · last May 2020
- 77 months since last filing
- Federal contracts
- $1.9M
- 1 award · Health and Human S
- Rank in Biotech#140 of 4373
- Granted patents
- None on recordNo USPTO grants. Applications publish after 18 months.
Capital timeline
Latest events
- Federal contractHealth and Human S · Pcmid SBIR Topic 85$1.9M
- Private capital raisedForm D · SEC · 1st filing$3.1M
- Federal grantHealth and Human S · Phase I · Fully Human Antibodies for the Prevention of Respiratory Syncytial Virus$300K
- Federal grantHealth and Human S · Phase I · Fully Human Antibody Combinations for the Prevention of Seasonal Influenza Infection$295K
- Federal grantHealth and Human S · Phase I · Fully Human Antibody Combinations for the Prevention of Seasonal Influenza Infection$295K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
9months
from IDBIOLOGICS INC’s first federal award to its first private round.
- First federal award · Aug 2019
- Health and Human S · $295K
- First Form D · May 2020
- $3.1M · 1st Form D
- Awards before first raise
- 3 awards
An association in public records, not a cause or a prediction.
Standing among 392 peers
Line = medianBiotech · Molecule
- Federal grants#99 · top 25%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Charles F. HainesResearcherExecutive Officer, DirectorLinked by $595K in grants as PI
- James E. Crowe, Jr.DirectorNamed in SEC Form D filings
- Kenneth J. KelleyDirectorNamed in SEC Form D filings
- Mike E. LaBarreDirectorNamed in SEC Form D filings
What it has protected
No granted patents are on record.
USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.
Checked: USPTO granted patents and published applications · Oct 23, 2026
Related companies, and why
- PEARL BIO, INC.Similar federal contract value in Biotech · $1.9M in contracts
- GLYCAN THERAPEUTICS CORPORATIONSimilar federal contract value in Biotech · $1.9M in contracts
- NAVIPOINT GENOMICS LLCSimilar federal contract value in Biotech · $1.9M in contracts
- PHOTOLITEC LLCSimilar federal contract value in Biotech · $1.9M in contracts
- MAXCYTE, INC.Similar federal contract value in Biotech · $1.9M in contracts
- ABZYME THERAPEUTICS LLCSimilar federal contract value in Biotech · $1.8M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .